RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 131 filers reported holding RELAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 13.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,304,140 | +236.6% | 1,700,849 | +402.7% | 0.00% | +200.0% |
| Q2 2023 | $4,249,236 | +124.9% | 338,315 | +194.9% | 0.00% | – |
| Q1 2023 | $1,889,422 | -11.3% | 114,719 | -19.5% | 0.00% | – |
| Q4 2022 | $2,129,847 | -78.2% | 142,560 | -67.3% | 0.00% | -100.0% |
| Q3 2022 | $9,752,000 | +117.6% | 435,940 | +62.9% | 0.00% | +100.0% |
| Q2 2022 | $4,482,000 | +49.6% | 267,619 | +167.4% | 0.00% | 0.0% |
| Q1 2022 | $2,995,000 | -61.4% | 100,094 | -60.4% | 0.00% | -50.0% |
| Q4 2021 | $7,763,000 | -0.3% | 252,759 | +2.4% | 0.00% | +100.0% |
| Q3 2021 | $7,783,000 | +67.2% | 246,847 | +94.0% | 0.00% | 0.0% |
| Q2 2021 | $4,656,000 | +6.2% | 127,251 | +0.4% | 0.00% | 0.0% |
| Q1 2021 | $4,383,000 | +67.4% | 126,773 | +101.2% | 0.00% | 0.0% |
| Q4 2020 | $2,618,000 | +13.6% | 62,997 | +16.5% | 0.00% | 0.0% |
| Q3 2020 | $2,304,000 | – | 54,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |